Firms

YZR Capital

YZR Capital

Munich, Germany

YZR Capital is a founder-led Munich healthcare venture investment firm. Its native imprint identifies the legal manager as YZR Capital GmbH, represented by co-founders and managing partners Reinhard Meier and Markus Feuerecker. The firm backs European healthcare companies from pre-seed through Series B, combining physician, operating, venture-capital and private-equity experience. Its three published investment themes are improving patient care, increasing provider efficiency and innovating healthcare value chains. Current native portfolio examples include dehaze’s AI chronic-disease detection, roclub’s medtech teleoperation, Scan.com’s medical-imaging marketplace, Biorce’s AI-assisted clinical-development technology, deepeye Medical, DeepLife, DaphOS and apoQlar. Its own published team directory names ten investment, advisory and venture-partner team members with substantive biographies and authentic portraits. The firm’s own 2023 disclosure explicitly confirms a second closing of YZR Capital Fund I and welcomes KfW Capital alongside EIF, Bertelsmann Investments and Beiersdorf. A later manager disclosure describes its healthtech-focused EUR100 million Fund I, but the exact final-close date and a directly itemized closed-capital allocation are not established by the retrieved primary materials. The fund is recorded as a verified operating vehicle with its cash amount/date left unspecified rather than treating the original target or a reported platform figure as an exact closing. Scripta Therapeutics’ 2025 seed financing explicitly includes YZR Capital as a participant; the company develops AI- and imaging-supported transcription-factor therapies relevant to neurodegenerative disease. Primary portfolio membership confirms institutional relationships without establishing the date, stage, lead status or individual check of every portfolio investment. YZR’s charitable foundation and affiliated founders’ historical personal investments are distinguished from manager fund cash.

Founded
—
Type
Venture capital

Funds1

  • YZR Capital Fund I—

    Verified operating healthtech venture fund. Manager’s primary public post explicitly confirms secondclose and LPs KfW Capital, EIF, Bertelsmann Investments and Beiersdorf. A later manager post describes EUR100million FundI. Exact final-close day and directly corroborated finalcapital subscriptions notestablished, so amount/dateNULL; reported100Msize retained here without convertingoriginaltarget or qualitativeownstatementinto exactfinalclose. No secondfund or charitablefoundationcash vehicle invented.

Team

Operations and support

Elmar H. WillebrandElmar H. WillebrandSenior Advisor
Holger EbersbergerHolger EbersbergerVenture Partner
Markus FeuereckerMarkus FeuereckerCo-Founder & Managing Partner
Martina SamwerMartina SamwerVenture Partner
Michael BitzerMichael BitzerSenior Advisor
Reinhard MeierReinhard MeierCo-Founder & Managing Partner
Till QuitzauTill QuitzauInvestor
Urs KellerUrs KellerVenture Partner

Co-investing

Investments